Home   >  
Ion Channel/Membrane Transporter
  • Cell Cycle/DNA Damage
  >  
TRP Channel
  • PPAR
  >   Rosiglitazone maleate
Rosiglitazone maleate Chemical Structure

Rosiglitazone maleate

Data Sheet For research use only. Not for human use.
Cat. No. :BCP05335CAS No. :155141-29-0Purity:98%
 Tel: 0086-17754423994   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 155141-29-0 Cat. No. BCP05335
Name Rosiglitazone maleate
Synonyms BRL 49653C;Avandia;
SMILES
Chemical Name
Formula C22H23N3O7S M. Wt 473.5
Purity 98% Storage Store at 4-8°C
Description in vitro: In competition experiments, rosiglitazone (BRL-49653), a potent antihyperglycemic agent, binds with high affinity to sites in intact adipocytes (IC50 = 12, 4 and 9 nM for rat, 3T3-L1 and human adipocytes, respectively). Rosiglitazone could induce AMP-activated protein kinase (AMPK) phosphorylation and reduce p70S6 kinase phosphorylation. Inhibition of AMPK impaired autophagy activation and enhanced palmitate-induced apoptosis during rosiglitazone treatment. Rosiglitazone-treated beta-cells were more resistant to palmitate-induced apoptosis. The conversion of LC3-I to LC3-II and accumulated autophagosomes were found to be upregulated in rosiglitazone-treated cells [2]. in vivo: In LFD mice with AP, Rosiglitazone(RGZ) significantly worsened the degree of intrapancreatic acinar and fat necrosis as well as visceral fat saponification, without affecting other parameters of disease severity or inflammation. Induction of AP lead to major suppression of adiponectin levels at Day 7 in
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:Rosiglitazone maleate supplier,Rosiglitazone maleate purchase,Rosiglitazone maleate manufacturer,Rosiglitazone maleate distributor,Rosiglitazone maleate cost,Rosiglitazone maleate buy,Rosiglitazone maleate for sale

0086-13720134139